Order Article Reprints

Wawruch M, Murin J, Tesar T, Petrova M, Paduchova M, Celovska D, Havelkova B, Trnka M, Masarykova L, Alfian SD, et al. Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease. Biomedicines. 2023; 11(2):368. https://doi.org/10.3390/biomedicines11020368

Wawruch, Martin, Jan Murin, Tomas Tesar, Miriam Petrova, Martina Paduchova, Denisa Celovska, Beata Havelkova, Michal Trnka, Lucia Masarykova, Sofa D. Alfian, and et al. 2023. "Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease" Biomedicines 11, no. 2: 368. https://doi.org/10.3390/biomedicines11020368

Wawruch, M., Murin, J., Tesar, T., Petrova, M., Paduchova, M., Celovska, D., Havelkova, B., Trnka, M., Masarykova, L., Alfian, S. D., & Aarnio, E. (2023). Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease. Biomedicines, 11(2), 368. https://doi.org/10.3390/biomedicines11020368